PLUS1
4.64
0.00 (0.0%)
0.00 (0.0%)
Upgrade to Real-Time
Premarket
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| DiaMedica Therapeutics Inc | DMAC | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Low Price | High Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.0% | 4.64 | 0.00 | 0.00 | 0.00 | 4.64 | 07:00:09 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 4.00 | 5.50 | 1.50 | 27.27% | - | - |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 4.64 | USD |
DiaMedica Therapeutics Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 65.61M | 14.14M | 10.74M | $ - | $ - | -0.73 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | 1.00 | - |
DiaMedica Therapeutics News
| Date | Time | Source | News Article |
|---|---|---|---|
| 5/19/2020 | 16:42 | Business Wire | DiaMedica Therapeutics to Present at the 17th Annual.. |
| 5/13/2020 | 16:41 | Business Wire | DiaMedica Announces Positive Results in Top-Line Data From.. |
| 5/13/2020 | 16:40 | Business Wire | DiaMedica Announces Positive Results in Top-Line Data from.. |
| 5/13/2020 | 16:38 | Edgar (US Regulatory) | Quarterly Report (10-q) |
| 5/13/2020 | 16:37 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 5/07/2020 | 16:30 | Business Wire | DiaMedica Therapeutics to Report First Quarter 2020.. |
| 4/20/2020 | 07:31 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical DMAC Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 4.73 | 5.00 | 4.00 | 4.61 | 61,274 | -0.09 | -1.9% |
| 1 Month | 4.0958 | 5.10 | 3.243 | 4.53 | 102,111 | 0.5442 | 13.29% |
| 3 Months | 3.96 | 5.10 | 1.87 | 3.96 | 54,556 | 0.68 | 17.17% |
| 6 Months | 3.15 | 5.875 | 1.87 | 4.24 | 57,289 | 1.49 | 47.3% |
| 1 Year | 2.76 | 5.93 | 1.70 | 4.02 | 68,218 | 1.88 | 68.12% |
| 3 Years | 4.00 | 5.93 | 1.70 | 3.86 | 64,274 | 0.64 | 16.0% |
| 5 Years | 4.00 | 5.93 | 1.70 | 3.86 | 64,274 | 0.64 | 16.0% |
DiaMedica Therapeutics Description
| DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company. It is principally engaged in the business activity of developing treatments for unmet clinical need or where no therapies are available with a primary focus on chronic kidney disease and acute ischemicstroke. Its pipeline product DM199 is a recombinant form of human tissue kallikrein-1. |
